Examinando por Materia "COVID -19"

Seleccione resultados tecleando las primeras letras
Mostrando 1 - 1 de 1
  • Miniatura
    PublicaciónAcceso abierto
    Características clínicas, comorbilidades y mortalidad en pacientes con COVID-19 de la Unidad de Cuidados Intensivos 8 del Hospital Nacional Guillermo Almenara Irigoyen. Enero–mayo 2021. Lima 2022
    (Universidad Privada Norbert Wiener, 2022-09-09) Araujo Aviles, Ivon Izen; Caldas Herrera, Emma
    Objective: Analyze the relationship between clinical characteristics, comorbidities, and mortality in COVID-19 patients in ICU 8 at HNGAI, January-May 2021. Method: This study uses a quantitative approach, applied type, with an observational, cross-sectional, and non-experimental design. The sample consisted of 175 medical records. The instrument used was a data collection sheet where all the information from the medical records was recorded. The results were clear, aligned with the objectives, and supported by the statistical test used in this research, which is the Chi-square test with a significance level of 5%. Results: It was observed that the highest percentage of deceased patients admitted to the Intensive Care Unit were identified as adults (9.10%) and male (13.70%), with a duration of illness greater than 7 days (12.69%), moderate oxygen saturation levels (9.10%) and PaO2/FiO2 (9.10%), a severe percentage of pulmonary parenchyma involvement (6.90%), altered levels of C-reactive protein (16.00%) and D-dimer (13.10%), normal ferritin levels (11.40%), and a history of comorbidities, including obesity (3.40%), hypertension (1.70%), diabetes mellitus (1.70%), asthma (0.60%), and in some cases, up to two comorbidities (0.60%). Hypothesis testing determined that there is a statistically significant relationship between age and mortality (p: 0.01), duration of illness and mortality (p: 0.008), and C-reactive protein levels and mortality (p: 0.016). Conclusion: It was concluded that there is a statistically significant relationship between age and mortality, duration of illness and mortality, and C-reactive protein levels and mortality in COVID-19 patients.